The Performance Evaluation Plan (PEP) is a regulatory document that describes how you (the manufacturer) plan to identify, screen, assess and analyse relevant clinical evidence that supports the performance of your in vitro diagnostic medical device. The outcome of this plan will be documented in the Scientific Validity Report, Analytical Performance Report, Clinical Performance Report and will be summarized in the Performance Evaluation Report.
The PEP will follow the requirements as defined in the European In-Vitro Diagnostic Regulation 2017/746 (IVDR), Annex XIII, Part A, Section 1.1. The PEP will include an IVDR-compliant State of the Art (SotA) description.
AML Christensen ApS
Agern Allé 5A
2970 Hoersholm, Denmark
CVR. 41553006
E-mail: anna@amlchristensen.com
Phone: +45 23 67 16 00
Fill out the form and one of our experts will get back to you in 24 hours, or reach out to us directly by emailing info@amlgroup.dk.